PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
PHASE2
Background:
One way to treat liver cancer is to deliver chemotherapy drugs...
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma
PHASE4
The purpose of this study is to determine whether the rituximab administrat...